Matches in Nanopublications for { ?s <http://www.w3.org/2000/01/rdf-schema#label> ?o ?g. }
- SENTENCE label "CONCLUSIONS Among patients undergoing laparoscopic cholecystectomy, those who gargled with 0.05% dexamethasone solution exhibited lower severity of POST than the control group, and those whose endotracheal tube cuff was soaked in 0.05% dexamethasone solution before intubation exhibited significantly lower incidence and severity of BACKGROUND Postoperative sore throat (POST) than the control group." provenance.
- SENTENCE label "CONCLUSIONS Among patients undergoing laparoscopic cholecystectomy, those who gargled with 0.05% dexamethasone solution exhibited lower severity of POST than the control group, and those whose endotracheal tube cuff was soaked in 0.05% dexamethasone solution before intubation exhibited significantly lower incidence and severity of BACKGROUND Postoperative sore throat (POST) than the control group." provenance.
- SENTENCE label "CONCLUSIONS Among patients undergoing laparoscopic cholecystectomy, those who gargled with 0.05% dexamethasone solution exhibited lower severity of POST than the control group, and those whose endotracheal tube cuff was soaked in 0.05% dexamethasone solution before intubation exhibited significantly lower incidence and severity of BACKGROUND Postoperative sore throat (POST) than the control group." provenance.
- SENTENCE label "CONCLUSIONS Among patients undergoing laparoscopic cholecystectomy, those who gargled with 0.05% dexamethasone solution exhibited lower severity of POST than the control group, and those whose endotracheal tube cuff was soaked in 0.05% dexamethasone solution before intubation exhibited significantly lower incidence and severity of BACKGROUND Postoperative sore throat (POST) than the control group." provenance.
- SENTENCE label "CONCLUSIONS Among patients undergoing laparoscopic cholecystectomy, those who gargled with 0.05% dexamethasone solution exhibited lower severity of POST than the control group, and those whose endotracheal tube cuff was soaked in 0.05% dexamethasone solution before intubation exhibited significantly lower incidence and severity of BACKGROUND Postoperative sore throat (POST) than the control group." provenance.
- SENTENCE label "CONCLUSIONS Among patients undergoing laparoscopic cholecystectomy, those who gargled with 0.05% dexamethasone solution exhibited lower severity of POST than the control group, and those whose endotracheal tube cuff was soaked in 0.05% dexamethasone solution before intubation exhibited significantly lower incidence and severity of BACKGROUND Postoperative sore throat (POST) than the control group." provenance.
- SENTENCE label "CONCLUSIONS Among patients undergoing laparoscopic cholecystectomy, those who gargled with 0.05% dexamethasone solution exhibited lower severity of POST than the control group, and those whose endotracheal tube cuff was soaked in 0.05% dexamethasone solution before intubation exhibited significantly lower incidence and severity of BACKGROUND Postoperative sore throat (POST) than the control group." provenance.
- SENTENCE label "CONCLUSIONS Among patients undergoing laparoscopic cholecystectomy, those who gargled with 0.05% dexamethasone solution exhibited lower severity of POST than the control group, and those whose endotracheal tube cuff was soaked in 0.05% dexamethasone solution before intubation exhibited significantly lower incidence and severity of BACKGROUND Postoperative sore throat (POST) than the control group." provenance.
- SENTENCE label "Conclusion Early administration of dexamethasone may prevent the progression of COVID-19 to a severe disease, without increased mortality." provenance.
- SENTENCE label "Conclusion Early administration of dexamethasone may prevent the progression of COVID-19 to a severe disease, without increased mortality." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." provenance.
- SENTENCE label "A similar process is also seen with the anti-inflammatory drugs methyl prednisolone and dexamethasone, used for Covid-19 patients." provenance.
- SENTENCE label "A similar process is also seen with the anti-inflammatory drugs methyl prednisolone and dexamethasone, used for Covid-19 patients." provenance.
- SENTENCE label "A similar process is also seen with the anti-inflammatory drugs methyl prednisolone and dexamethasone, used for Covid-19 patients." provenance.
- SENTENCE label "A similar process is also seen with the anti-inflammatory drugs methyl prednisolone and dexamethasone, used for Covid-19 patients." provenance.
- SENTENCE label "the synthetic glucocorticoid, dexamethasone (Dex) treatment did not appear to affect Dams treated with Dex ability to get pregnant, as both groups carried pups to term with similar lengths of gestation (p=0.838)." provenance.
- SENTENCE label "the synthetic glucocorticoid, dexamethasone (Dex) treatment did not appear to affect Dams treated with Dex ability to get pregnant, as both groups carried pups to term with similar lengths of gestation (p=0.838)." provenance.
- SENTENCE label "the synthetic glucocorticoid, dexamethasone (Dex) treatment did not appear to affect Dams treated with Dex ability to get pregnant, as both groups carried pups to term with similar lengths of gestation (p=0.838)." provenance.
- SENTENCE label "the synthetic glucocorticoid, dexamethasone (Dex) treatment did not appear to affect Dams treated with Dex ability to get pregnant, as both groups carried pups to term with similar lengths of gestation (p=0.838)." provenance.
- SENTENCE label "the synthetic glucocorticoid, dexamethasone (Dex) treatment did not appear to affect Dams treated with Dex ability to get pregnant, as both groups carried pups to term with similar lengths of gestation (p=0.838)." provenance.
- SENTENCE label "the synthetic glucocorticoid, dexamethasone (Dex) treatment did not appear to affect Dams treated with Dex ability to get pregnant, as both groups carried pups to term with similar lengths of gestation (p=0.838)." provenance.
- SENTENCE label "All combinations of three factors (inoculation with Salmonella choleraesuis on Day 0, PRRSV on Day 3, and treatment with dexamethasone on Days 3–7) were used to produce eight treatment groups in two independent trials." provenance.
- SENTENCE label "All combinations of three factors (inoculation with Salmonella choleraesuis on Day 0, PRRSV on Day 3, and treatment with dexamethasone on Days 3–7) were used to produce eight treatment groups in two independent trials." provenance.
- SENTENCE label "All combinations of three factors (inoculation with Salmonella choleraesuis on Day 0, PRRSV on Day 3, and treatment with dexamethasone on Days 3–7) were used to produce eight treatment groups in two independent trials." provenance.
- SENTENCE label "All combinations of three factors (inoculation with Salmonella choleraesuis on Day 0, PRRSV on Day 3, and treatment with dexamethasone on Days 3–7) were used to produce eight treatment groups in two independent trials." provenance.
- SENTENCE label "All combinations of three factors (inoculation with Salmonella choleraesuis on Day 0, PRRSV on Day 3, and treatment with dexamethasone on Days 3–7) were used to produce eight treatment groups in two independent trials." provenance.
- SENTENCE label "All combinations of three factors (inoculation with Salmonella choleraesuis on Day 0, PRRSV on Day 3, and treatment with dexamethasone on Days 3–7) were used to produce eight treatment groups in two independent trials." provenance.
- SENTENCE label "All combinations of three factors (inoculation with Salmonella choleraesuis on Day 0, PRRSV on Day 3, and treatment with dexamethasone on Days 3–7) were used to produce eight treatment groups in two independent trials." provenance.
- SENTENCE label "All combinations of three factors (inoculation with Salmonella choleraesuis on Day 0, PRRSV on Day 3, and treatment with dexamethasone on Days 3–7) were used to produce eight treatment groups in two independent trials." provenance.
- SENTENCE label "All combinations of three factors (inoculation with Salmonella choleraesuis on Day 0, PRRSV on Day 3, and treatment with dexamethasone on Days 3–7) were used to produce eight treatment groups in two independent trials." provenance.
- SENTENCE label "All combinations of three factors (inoculation with Salmonella choleraesuis on Day 0, PRRSV on Day 3, and treatment with dexamethasone on Days 3–7) were used to produce eight treatment groups in two independent trials." provenance.
- SENTENCE label "All combinations of three factors (inoculation with Salmonella choleraesuis on Day 0, PRRSV on Day 3, and treatment with dexamethasone on Days 3–7) were used to produce eight treatment groups in two independent trials." provenance.
- SENTENCE label "All combinations of three factors (inoculation with Salmonella choleraesuis on Day 0, PRRSV on Day 3, and treatment with dexamethasone on Days 3–7) were used to produce eight treatment groups in two independent trials." provenance.
- SENTENCE label "All combinations of three factors (inoculation with Salmonella choleraesuis on Day 0, PRRSV on Day 3, and treatment with dexamethasone on Days 3–7) were used to produce eight treatment groups in two independent trials." provenance.
- SENTENCE label "All combinations of three factors (inoculation with Salmonella choleraesuis on Day 0, PRRSV on Day 3, and treatment with dexamethasone on Days 3–7) were used to produce eight treatment groups in two independent trials." provenance.
- SENTENCE label "All combinations of three factors (inoculation with Salmonella choleraesuis on Day 0, PRRSV on Day 3, and treatment with dexamethasone on Days 3–7) were used to produce eight treatment groups in two independent trials." provenance.
- SENTENCE label "In this case series, we share we's experience in using dexamethasone in five COVID-19 infected patients with acute respiratory distress syndrome." provenance.
- SENTENCE label "In this case series, we share we's experience in using dexamethasone in five COVID-19 infected patients with acute respiratory distress syndrome." provenance.
- SENTENCE label "In this case series, we share we's experience in using dexamethasone in five COVID-19 infected patients with acute respiratory distress syndrome." provenance.
- SENTENCE label "Eligible and consenting patients were randomly allocated to either usual standard of care alone or usual standard of care plus Lopinavir-ritonavir (400 mg and 100 mg, respectively) by mouth for 10 days or until discharge (or one of the other RECOVERY treatment groups: hydroxychloroquine, dexamethasone, or azithromycin) using web-based simple (unstratified) randomisation with allocation concealment." provenance.
- SENTENCE label "Eligible and consenting patients were randomly allocated to either usual standard of care alone or usual standard of care plus Lopinavir-ritonavir (400 mg and 100 mg, respectively) by mouth for 10 days or until discharge (or one of the other RECOVERY treatment groups: hydroxychloroquine, dexamethasone, or azithromycin) using web-based simple (unstratified) randomisation with allocation concealment." provenance.
- SENTENCE label "Eligible and consenting patients were randomly allocated to either usual standard of care alone or usual standard of care plus Lopinavir-ritonavir (400 mg and 100 mg, respectively) by mouth for 10 days or until discharge (or one of the other RECOVERY treatment groups: hydroxychloroquine, dexamethasone, or azithromycin) using web-based simple (unstratified) randomisation with allocation concealment." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.
- SENTENCE label "Mesenchymal stem cells (MSCs), which release immunomodulatory factors such as tumor necrosis factor-α (TNF)-α)-induced gene/protein 6 (TSG)-6) and prostaglandin E2 (PGE2), have been suggested as an alternative therapeutic option for Canine inflammatory bowel disease (IBD) treatment in veterinary medicine." provenance.